Joshua Riggs's Insider Trades & SAST Disclosures

Joshua Riggs's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 188,679 Restricted Stock Units done . Disclosure was reported to the exchange on March 26, 2025.

Share

Note

This is a custom search result for pattern Joshua Riggs.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Insight Molecular Diagnost...	Joshua Riggs	CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Mar 2025	188,679	188,679	-		-	Restricted Stock Units
Insight Molecular Diagnost...	Joshua Riggs	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 May 2024	90,000	90,000	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Joshua Riggs	Director, CEO and President	Purchase of securities on an exchange or from another person at price $ 2.95 per share.	11 Apr 2024	3,390	3,505 (0%)	0%	3.0	10,001	Common Stock, no par value
Insight Molecular Diagnost...	Joshua Riggs	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Aug 2023	40,000	40,000	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Joshua Riggs	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2023	800,000	800,000	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Joshua Riggs	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2023	350,000	350,000	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Joshua Riggs	CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2023	116,426	116,426	-		-	Option to Purchase Common Stock
Insight Molecular Diagnost...	Joshua Riggs	Interim CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2023	257,485	257,485	-		-	Option to Purchase Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades